Reneuron Share Discussion Threads

[jensonbensonjohnson] 05/3/2019 09:01

At least the stem cell story is keeping Brexit off the top spot on the news :)

[stewart_25] 05/3/2019 08:28

who is ramping #letmepass?

[rocket fuel] 05/3/2019 08:22

Watch out below!

[someuwin] 05/3/2019 08:13

Stem Cell treatment cures HIV. Lead story on BBC news now.



Stem Cell treatment cures blindness thanks to RENE next?

[city chappy] 05/3/2019 07:45

This should already be over £12 on the perfect retinal results last month. Takeover for a couple of billion after more good readouts mid year.

[letmepass] 05/3/2019 07:43

Big boys selling but how much and why?

[rayrac] 05/3/2019 07:41

Invesco reduce...is that right?

[small crow] 05/3/2019 07:32

Ten quid is realistic here I think. Imagine if the blindness therapy scales up well in later phase trials....

[bonzo] 05/3/2019 07:22

Let's pray we don't get bought out too soon. £10 target!

[small crow] 05/3/2019 07:08

Major investors onboard. More to come??

[buywell2] 05/3/2019 05:52

Gap filled

A chance to raise some hard needed cash ?

Meaningful Clinical Phase 3 trials cost a bomb

[cottoner] 05/3/2019 05:44

Syncona finds Americans’ offer for Nightstar too good to refuse

'Nightstar Therapeutics, a clinical-stage gene therapy specialist founded by Syncona, the FTSE 250 investment company, has agreed an $877 million sale to Biogen, the $66 billion US-listed biotech group. The deal values Nightstar, which also is listed in the United States, at $25.50 per share, a premium of about 70 per cent'

'Nightstar is developing treatments for rare inherited retinal diseases that would otherwise lead to blindness. Its most advanced asset is a treatment for patients with choroideremia, which is in enrolling patients in a phase III study. The genetic disorder has no treatment at present and affects about one in 50,000 people.'




================================================================================

Another gene therapy specialist developing treatments for retinal diseases is bought out and there a very large buys going thro' in RENE.

Current RENE mcap - c£24m.

Something stirring - should find out what soon.

[supernumerary] 04/3/2019 22:25

It is today, but they're spending £20M a year. It doesn't take long at that rate to reestablish a balance, as long-term holders will no doubt confirm....

[hsm12] 04/3/2019 22:18

Even after this move and with its assets, it's still technically trading below cash.

[letmepass] 04/3/2019 21:14

Haha ramper's at work

[city chappy] 04/3/2019 21:04

1222p only puts it back where it was in 2009 and is still small beer at just £400m.



It was over £48 in early 2007.

Not too many shares in issue either.

[stewart_25] 04/3/2019 20:34

City chappy - i would be happy with 1222 - been holding that bloody hell a Break Even would be a bloody bonus lol

[stewart_25] 04/3/2019 20:33

JBJ - I was so excited by the stroke results - on the BBC as well but share price just dropped and dropped since - Agree - with good news that has decent coverage and gaining interest this should fly. AIMHO....

[jensonbensonjohnson] 04/3/2019 19:53

To be honest I've lost a bit of faith in the stroke therapy. I'm much more hopeful for the retinal treatment and the exosome potential.

That said, any one of them succeeding will send RENE absolutely ballistic.

[yachtmaster2] 04/3/2019 18:47

Indeed Jenson. Also remember seeing a video of an old chap who recovered from his
Stroke after being a clinical trial patient.Whatever became of that?

[city chappy] 04/3/2019 18:16

When I saw the good results data from all three patients in the first cohort of the Phase II retinal trial last month, I thought RENE should already be a £400m company just for starters - particularly as the treatment has the coveted Orphan Drug Designation in both Europe and the US, plus Fast Track designation from the FDA.

That's more than sixteen times the current share price right now, i.e. 1222p

Time to catch up then sell the company for a couple of billion mid year on more good results.

[jensonbensonjohnson] 04/3/2019 17:25

I hope they don't put out a, "We know of no reason for the recent share price rise" RNS. I seem to remember them doing that once in the dim and distant!

[yachtmaster2] 04/3/2019 16:59

LOL Jenson. £4 would have have me showing a small profit on what I have left!

[jensonbensonjohnson] 04/3/2019 16:31

Doh! Make that £40